{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibpzhx6vb7wyx2jjaby6yw5n7mponw62e6n5lu2mxpbltqtwv6wau",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mejw4lcc2bu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreid5lafutb56yv2giv5z4n2qppjuhm7iyaxm4wpx72m4rlos5ihkwe"
    },
    "mimeType": "image/jpeg",
    "size": 644353
  },
  "path": "/news/2026-02-combination-treatment-disease-advanced-sarcoma.html",
  "publishedAt": "2026-02-10T16:27:45.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Oncology & Cancer"
  ],
  "textContent": "An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet Oncology. \"These findings support the combination as a potential treatment option for patients with advanced leiomyosarcoma and provide a strong rationale for further study aimed at improving outcomes in this difficult-to-treat cancer,\" said Seth Pollack, MD, the Steven T. Rosen, MD, Professor of Cancer Biology and a co-author of the study.",
  "title": "Combination treatment may slow disease progression in advanced sarcoma"
}